Albaron Partners has announced the close of its flagship fund.
The fund, Albaron Healthcare Opportunities I, closed with $185 million. It was oversubscribed.
Albaron, founded in 2017 and based in New York, is a lower middle market private equity firm. The firm focuses on investing in North American healthcare and healthcare services companies generating…
Salt Creek Capital has announced the acquisition of MML Diagnostics Packaging.
MML, founded in 1964 and headquartered in Troutdale, Oregon, is a contract manufacturer and packager of in-vitro diagnostic devices and single-use medical devices.
Salt Creek, founded in 2009 and based in Woodside, California, is a private equity firm that invests in the…
Kinderhook Industries has completed its acquisition of Enhabit, according to a news release.
The deal was valued at approximately $1.1 billion.
Enhabit, founded in 2022 when it was spun off from Encompass Health Corp. and based in Dallas, is a national home health and hospice provider.
Kinderhook, founded in 2003 and based…
Water Street Healthcare Partners has announced the closing of its sixth private equity fund.
The fund, Water Street Healthcare Partners VI, closed with $1.9 billion in total capital commitments. The fund was oversubscribed and closed at its hard cap.
Water Street, founded in 2005 and based in Chicago, is a private equity firm focused exclusively on…
The secondary market has grown to roughly $220 billion as GPs and LPs scramble for liquidity in a private markets cycle stuck in a “worse distribution profile” for three and a half years. Chris Lawrence, managing partner at Labyrinth Capital Partners, joins McGuireWoods partner and host Geoff Cockrell to demystify GP-led secondaries.
Chris…
Eir Partners has acquired a controlling interest in QuartzBio, according to a news release.
QuartzBio, founded in 2012 and based in Frederick, Maryland, is a life science technology company that provides connected sample and biomarker intelligence for clinical-stage biopharma.
Eir, founded in 2015 and based in Miami, is a middle market private…
Brightstar Capital Partners has announced an investment in Simon Eye Holdings.
Simon Eye, founded in 1987 and based in Wilmington, Delaware, is an integrated vision care platform providing optometry, optical and ophthalmology services across the Mid-Atlantic region.
Brightstar, founded in 2015 and with headquarters in New York and West Palm Beach, Florida, is…
THL Partners has announced the closing of its newest fund.
The fund — THL Equity Fund X — closed with $6.35 billion in investable capital.
THL, founded in 1974 and based in Boston, is a private equity firm investing in middle market growth companies in a few sectors, including healthcare. The firm typically targets…
Mako Capital Group has announced its launch.
Mako, based in Miami, is a private equity firm specializing in acquiring lower-middle market U.S. companies in healthcare, financial and other services. Mako targets businesses with $5 million to $15 million of EBITDA and invests $25 million to $50 million of equity per transaction. The firm was…
Oncology commands roughly 40% of the national drug spend. Retina is close behind. “If you follow the drug spend, you’ll find that the distributors are really building an ecosystem around it,” says Jeanne Proia, managing director at Cross Keys Capital and president of its healthcare services group.
In this conversation with McGuireWoods partner…
